Physician profile
Brian E Schulze
NPI 1407960685
$2,659.47
in general payments reported to CMS, 2019-2025
8 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $20.29 · 2021: $13.76 · 2023: $2,069 · 2024: $14.06 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,398 · Food and Beverage: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,397.50 |
| Food and Beverage | $1,080.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,084.59 | 2023-2025 | Or3o Dual Mobility, Ri Hip Navigation, Journey |
| Davol INC. | $266.25 | 2021-2025 | Surgiphor, Arista Ah Flexitip |
| Bard Access Systems, INC. | $146.57 | 2019 | |
| Acumed LLC | $84.41 | 2025 | Acumed |
| Fidia Pharma USA INC. | $24.15 | 2023 | Triluron, Hymovis |
| Orthofix Medical, INC. | $20.04 | 2019-2024 | Physio-Stim |
| Becton, Dickinson and Company | $18.22 | 2025 | Surgiphor |
| Vericel Corporation | $15.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Schulze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.